Concepedia

John Andrejack

JA

3

Publications

80

Citations

3

H-Index

1969

Active since

Affiliations

Parkinson's Foundation(Current)

University of Cambridge

UCB Pharma (Belgium)

UCB Pharma (Germany)

Parkinson's UK

John Andrejack is an author at Parkinson's Foundation specializing in drug analysis, engineering, and organic chemistry.

Top concepts

Publications per year

1969–2023

3

Publications

3

Patient Experience in Early-Stage Parkinson’s Disease: Using a Mixed Methods Analysis to Identify Which Concepts Are Cardinal for Clinical Trial Outcome Assessment

Thomas Morel, Sophie Cleanthous, John Andrejack et al. · Neurology and Therapy · 2022 · 43 citations · Full text

Development and early qualitative evidence of two novel patient-reported outcome instruments to assess daily functioning in people with early-stage Parkinson’s

Thomas Morel, Sophie Cleanthous, John Andrejack et al. · Journal of Patient-Reported Outcomes · 2023 · 21 citations · Full text

2,3-Naphthotriazole as a gravimetric, spectrophotometric, and fluorimetric reagent for the determination of silver

Garry L. Wheeler, John Andrejack, James H. Wiersma et al. · Analytica Chimica Acta · 1969 · 16 citations

, , +7

Rows per page

1–3 of 3